117 related articles for article (PubMed ID: 38494066)
21. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
[TBL] [Abstract][Full Text] [Related]
22. EGR1 modulated LncRNA HNF1A-AS1 drives glioblastoma progression via miR-22-3p/ENO1 axis.
Ma C; Wang H; Zong G; He J; Wang Y; Yang F; Yang Z; Bian E; Zhao B
Cell Death Discov; 2021 Nov; 7(1):350. PubMed ID: 34772911
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
Liu HT; Ma RR; Lv BB; Zhang H; Shi DB; Guo XY; Zhang GH; Gao P
Br J Cancer; 2020 Jun; 122(12):1825-1836. PubMed ID: 32336754
[TBL] [Abstract][Full Text] [Related]
24. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
25. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
[TBL] [Abstract][Full Text] [Related]
26. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of
Jiang H; Su Z; Hu W; Yuan X; Yu T; Yang J; Xiao X; Zheng S; Lin B
OMICS; 2023 May; 27(5):215-226. PubMed ID: 37196148
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K/AKT signal pathway.
Yang L; Du C; Chen H; Diao Z
Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34784707
[TBL] [Abstract][Full Text] [Related]
28. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.
Lv D; Jia F; Hou Y; Sang Y; Alvarez AA; Zhang W; Gao WQ; Hu B; Cheng SY; Ge J; Li Y; Feng H
Cancer Res; 2017 Nov; 77(22):6190-6201. PubMed ID: 29021135
[TBL] [Abstract][Full Text] [Related]
29. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
30. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
[TBL] [Abstract][Full Text] [Related]
31. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
[TBL] [Abstract][Full Text] [Related]
32. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
[TBL] [Abstract][Full Text] [Related]
33. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
Cheng Y; Xie P
J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
[TBL] [Abstract][Full Text] [Related]
34. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
[TBL] [Abstract][Full Text] [Related]
35. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma.
Guo T; Wu C; Zhang J; Yu J; Li G; Jiang H; Zhang X; Yu R; Liu X
Cell Commun Signal; 2023 Dec; 21(1):363. PubMed ID: 38115126
[TBL] [Abstract][Full Text] [Related]
36. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
37. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
38. Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.
Zhang W; Dong J; Xu J; Qian Y; Chen D; Fan Z; Yang H; Xiang J; Xue X; Luo X; Jiang Y; Wang Y; Huang Z
Biochem Pharmacol; 2024 May; 223():116112. PubMed ID: 38458331
[TBL] [Abstract][Full Text] [Related]
39. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.
Hashemi M; Etemad S; Rezaei S; Ziaolhagh S; Rajabi R; Rahmanian P; Abdi S; Koohpar ZK; Rafiei R; Raei B; Ahmadi F; Salimimoghadam S; Aref AR; Zandieh MA; Entezari M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114204. PubMed ID: 36916430
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
Cheng Z; Luo C; Guo Z
J Cell Biochem; 2020 Mar; 121(3):2170-2183. PubMed ID: 31680298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]